San Diego, CA, United States of America

Suzanne Michiko Sato

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 6.9

ph-index = 6

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovations of Inventor Suzanne Michiko Sato

Introduction

Suzanne Michiko Sato is a notable inventor based in San Diego, California, who has made significant contributions to the field of pharmaceuticals. With a total of 10 patents to her name, Sato is recognized for her innovative work in developing novel compounds with potential therapeutic applications.

Latest Patents

One of her latest patents includes the processes for preparing (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and its salts. This invention relates to valuable processes and intermediates that are useful in the preparation of an S1P1 receptor modulator, which targets various disorders mediated by lymphocytes, including transplant rejection, autoimmune diseases, and inflammatory conditions. The compound is also relevant in treating cancer and afflictions associated with vascular integrity and angiogenesis, highlighting its significant medical relevance.

Career Highlights

Suzanne Sato has established her career at Arena Pharmaceuticals, Inc., where she focuses on innovative drug development. Her expertise in the field of pharmacology and chemistry has allowed her to lead research and development efforts that contribute to addressing critical health challenges.

Collaborations

Throughout her career, Sato has collaborated with notable colleagues such as Antonio Garrido Montalban and Daniel J Buzard. These partnerships emphasize the importance of teamwork in innovation and the advancement of pharmaceutical research.

Conclusion

In summary, Suzanne Michiko Sato is an accomplished inventor whose patents are paving the way for advancements in medical treatment. Her work at Arena Pharmaceuticals, Inc. and her collaborative approach continue to impact the pharmaceutical industry positively, showcasing the essence of innovation in addressing complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…